Skip to main content
Livermore
Livermore
ZHEN

Apriem Advisors

SEC CIK
0001425165
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Apriem Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
3,554
Value
$322.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Apriem Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,554$322.5K<0.1%+100+2.9%AddedHolders
Q1 20263,454$354.7K<0.1%+141+4.3%AddedHolders
Q4 20253,313$415.1K<0.1%+24+0.7%AddedHolders
Q3 20253,289$440.6K<0.1%+41+1.3%AddedHolders
Q2 20253,248$441.8K<0.1%00.0%UnchangedHolders
Q1 20253,248$430.9K0.1%−55−1.7%ReducedHolders
Q4 20243,303$373.6K<0.1%+161+5.1%AddedHolders
Q3 20243,142$358.2K<0.1%−78−2.4%ReducedHolders
Q2 20243,220$334.6K<0.1%−191−5.6%ReducedHolders
Q1 20243,411$387.7K<0.1%−18,611−84.5%ReducedHolders
Q4 202322,022$2.42M0.3%+208+1.0%AddedHolders
Q3 202321,814$2.11M0.3%−5,524−20.2%ReducedHolders
Q2 202327,338$2.98M0.4%+5,874+27.4%AddedHolders
Q1 202321,464$2.17M0.3%+17,911+504.1%AddedHolders
Q4 20223,553$390.1K0.1%00.0%UnchangedHolders
Q3 20223,553$344.0K0.1%+10.0%AddedHolders
Q2 20223,552$386.0K0.1%00.0%UnchangedHolders
Q1 20223,552$420.0K0.1%+120+3.5%AddedHolders
Q4 20213,432$483.0K0.1%+10+0.3%AddedHolders
Q3 20213,422$404.0K0.1%−200−5.5%ReducedHolders
Q2 20213,622$420.0K0.1%+50+1.4%AddedHolders
Q1 20213,572$428.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.